COMPASS Pathways plc (FRA:5Y6)
Germany · Delayed Price · Currency is EUR 7.75
+0.25 (3.33%)
Last updated: Apr 24, 2026, 9:55 AM CET
COMPASS Pathways Market Cap
COMPASS Pathways has a market cap or net worth of €1.05 billion as of April 24, 2026. Its market cap has increased by 360.18% in one year.
Market Cap
1.05B
Enterprise Value
956.12M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€7.75
Market Cap Chart
Since September 18, 2020, COMPASS Pathways's market cap has increased from 449.43M to 1.05B, an increase of 134.50%. That is a compound annual growth rate of 16.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 1.01B | 78.53% |
| Dec 31, 2025 | 564.27M | 125.88% |
| Dec 31, 2024 | 249.81M | -49.02% |
| Dec 29, 2023 | 489.98M | 53.16% |
| Dec 30, 2022 | 319.91M | -60.55% |
| Dec 31, 2021 | 810.94M | -42.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest Aktiengesellschaft | 1.45B |
| Darwin AG | 92.40M |
| 2invest AG | 49.52M |
| Biomark Diagnostics | 35.52M |
| co.don AG | 374.13K |
| Paion AG | 278.21K |
| bioXXmed AG | 244.68K |
| MagForce AG | 122.29K |